Rocket Pharmaceuticals, Inc. (RCKT) Free cash flow 2016–2025
Rocket Pharmaceuticals, Inc. (RCKT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$190.5MFY2025 · since FY2016: -$5.8M → -$190.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$190.5M | +11.7% |
| FY2024 | -$215.6M | -2.0% |
| FY2023 | -$211.4M | -13.3% |
| FY2022 | -$186.5M | -44.8% |
| FY2021 | -$128.8M | -35.2% |
| FY2020 | -$95.2M | -8.3% |
| FY2019 | -$87.9M | -59.2% |
| FY2018 | -$55.2M | -230.3% |
| FY2017 | -$16.7M | -186.4% |
| FY2016 | -$5.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RCKT financial trends
RCKT RevenueRCKT Net incomeRCKT Net marginRCKT Gross profitRCKT Gross marginRCKT Operating incomeRCKT Operating marginRCKT Operating cash flowRCKT Capital expendituresRCKT Return on equityRCKT Stock buybacksRCKT Dividends paidRCKT Total assetsRCKT Total liabilitiesRCKT Shareholders’ equityRCKT overview →